Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Roche Holding AG (OTCQX International Premier:RHHBY)

During the Trading Day
32.12 +0.15 / +0.47%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
32.12 0.00 / 0.00%
Volume: --
Cancer Immunotherapies Take Center Stage in Pre-ASCO Abstract Releases
10:44am / MotleyFool.com - Paid Partner Content
Roche Gets Accelerated Approval for Immunotherapy Drug
May 19 / Zacks.com - Paid Partner Content
Novartis Filing for MabThera Biosimilar Accepted in the EU
May 24 / Zacks.com - Paid Partner Content
Kite Pharma (KITE) Upgraded to Hold on Strong Fundamentals
May 13 / Zacks.com - Paid Partner Content
Ignore Intuitive Surgical, Inc.: Here Are 3 Better Stocks
May 23 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close31.97
Today’s open31.97
Day’s range31.97 - 32.15
Average volume (3 months)1,021,439
Market cap$174.9B
Dividend yield3.17%
Data as of 3:59pm ET, 05/26/2016

Growth & Valuation

Earnings growth (last year)-9.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+8.30%
Revenue growth (last year)-3.39%
P/E ratio--


No competitors data available.


Last reporting dateJanuary 28, 2016
EPS forecast (this quarter)$0.90
Annual revenue (last year)$50.0B
Annual profit (last year)$9.2B
Net profit margin18.41%


Health Technology
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Severin Schwan
Roche Diagnostics Division
Roland Diggelmann
Corporate headquarters
Basel, Basel-stadt (basle Town)


Partner Offers

Search for Jobs